Mr. Freyman served as Executive Vice President, Finance and Administration for Abbott Laboratories from June 2015 until his retirement in February 2017. Prior to that, he served as Chief Financial Officer and Executive Vice President, Finance for Abbott since 2004.
He was first appointed Chief Financial Officer and Senior Vice President, Finance in 2001. From 1999 to 2001, he served as Vice President and Controller of Abbott’s Hospital Products Division. Prior to that, he held a number of financial planning and analysis positions with Abbott including Treasurer for Abbott’s international operations and Corporate Vice President and Treasurer.
Mr. Freyman holds a bachelor’s degree in Accounting from the University of Illinois and a master’s degree in management from Northwestern University. Mr. Freyman is a director of Hanger, Inc. and AbbVie Inc. (formerly Allergan plc.)
Mr. Freyman has been a director of our company since 2013. As a former Chief Financial Officer of a Fortune 200 company,+ Mr. Freyman brings substaintial expertise in finance and accounting to our Board and our Audit Committee. Throughout his more than 30-year career with Abbott, Mr. Freyman served in diverse financial and acconting roles throughout Abbott's global organization.
Prior to his career with Abbott, he was a certified public accountant with the firm of Ernst & Whinney (now Ernst & Young) where he gained substaintial experience in auditing, tax and financial reporting. The Board has designated Mr. Freyman as an "audit committee financial expert" as that term is defined in the SEC's rules adopted pursuant to the Sarbanes-Oxley Act of 2002.
+ At the time of his retirement